105 related articles for article (PubMed ID: 35148944)
1. Risk assessment of micafungin-induced liver injury using spontaneous reporting system data and electronic medical records.
Asai Y; Yamamoto T; Sato Y
J Infect Chemother; 2022 May; 28(5):690-695. PubMed ID: 35148944
[TBL] [Abstract][Full Text] [Related]
2. Risk evaluation of ampicillin/sulbactam-induced liver injury based on albumin-bilirubin score.
Ooi H; Asai Y; Sato Y
J Infect Chemother; 2023 Sep; 29(9):900-904. PubMed ID: 37301371
[TBL] [Abstract][Full Text] [Related]
3. Effect of Ceftriaxone Dosage and Albumin-Bilirubin Score on the Risk of Ceftriaxone-Induced Liver Injury.
Ooi H; Asai Y; Koriyama Y; Takahashi M
Biol Pharm Bull; 2023; 46(12):1731-1736. PubMed ID: 38044131
[TBL] [Abstract][Full Text] [Related]
4. Baseline Albumin-Bilirubin (ALBI) Score in Western Patients With Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy (SBRT).
Murray LJ; Sykes J; Brierley J; Kim JJ; Wong RKS; Ringash J; Craig T; Velec M; Lindsay P; Knox JJ; Dawson LA
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):900-909. PubMed ID: 29976502
[TBL] [Abstract][Full Text] [Related]
5. Liver Function Assessment Using Albumin-Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation.
Oh IS; Sinn DH; Kang TW; Lee MW; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
Dig Dis Sci; 2017 Nov; 62(11):3235-3242. PubMed ID: 28983724
[TBL] [Abstract][Full Text] [Related]
6. Long-term risk of hepatocellular carcinoma mortality in 23220 hospitalized patients treated with micafungin or other parenteral antifungals.
Schneeweiss S; Carver PL; Datta K; Galar A; Johnson MD; Letourneau AR; Marty FM; Nagel J; Najdzinowicz M; Saul M; Schuster M; Shoham S; Silveira FP; Varughese C; Wilck M; Weatherby L; Oene JV; Walker AM
J Antimicrob Chemother; 2020 Jan; 75(1):221-228. PubMed ID: 31580432
[TBL] [Abstract][Full Text] [Related]
7. Preoperative albumin-bilirubin grade combined with aspartate aminotransferase-to-platelet count ratio index predict outcomes of patients with hepatocellular carcinoma within Milan criteria after liver resection.
Luo H; Li C; Chen L
Biosci Trends; 2019 May; 13(2):176-181. PubMed ID: 31061272
[TBL] [Abstract][Full Text] [Related]
8. Albumin-Bilirubin Score: An Accurate Predictor of Hepatic Decompensation in High-Risk Patients Undergoing Transarterial Chemoembolization for Hepatocellular Carcinoma.
Mohammed MAA; Khalaf MH; Liang T; Wang DS; Lungren MP; Rosenberg J; Kothary N
J Vasc Interv Radiol; 2018 Nov; 29(11):1527-1534.e1. PubMed ID: 30274856
[TBL] [Abstract][Full Text] [Related]
9. Signal Detection of Potential Hepatotoxic Drugs: Case-Control Study Using Both a Spontaneous Reporting System and Electronic Medical Records.
Akimoto H; Nagashima T; Minagawa K; Hayakawa T; Takahashi Y; Asai S
Biol Pharm Bull; 2021; 44(10):1514-1523. PubMed ID: 34602560
[TBL] [Abstract][Full Text] [Related]
10. Liver function assessment according to the Albumin-Bilirubin (ALBI) grade in sorafenib-treated patients with advanced hepatocellular carcinoma.
Ogasawara S; Chiba T; Ooka Y; Suzuki E; Kanogawa N; Saito T; Motoyama T; Tawada A; Kanai F; Yokosuka O
Invest New Drugs; 2015 Dec; 33(6):1257-62. PubMed ID: 26462681
[TBL] [Abstract][Full Text] [Related]
11. Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals.
Casadei Gardini A; Foschi FG; Conti F; Petracci E; Vukotic R; Marisi G; Buonfiglioli F; Vitale G; Ravaioli F; Gitto S; Verucchi G; Lenzi M; Bolondi L; Mazzella G; Brillanti S; Andreone P;
Dig Liver Dis; 2019 May; 51(5):681-688. PubMed ID: 30327251
[TBL] [Abstract][Full Text] [Related]
12. Short-term risk of liver and renal injury in hospitalized patients using micafungin: a multicentre cohort study.
Schneeweiss S; Carver PL; Datta K; Galar A; Johnson MD; Johnson MG; Marty FM; Nagel J; Najdzinowicz M; Saul M; Shoham S; Silveira FP; Varughese CA; Wilck M; Weatherby L; Auton T; Walker AM
J Antimicrob Chemother; 2016 Oct; 71(10):2938-44. PubMed ID: 27407049
[TBL] [Abstract][Full Text] [Related]
13. Hepatic Function during Repeated TACE Procedures and Prognosis after Introducing Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: Multicenter Analysis.
Hiraoka A; Kumada T; Kudo M; Hirooka M; Koizumi Y; Hiasa Y; Tajiri K; Toyoda H; Tada T; Ochi H; Joko K; Shimada N; Deguchi A; Ishikawa T; Imai M; Tsuji K; Michitaka K;
Dig Dis; 2017; 35(6):602-610. PubMed ID: 29040999
[TBL] [Abstract][Full Text] [Related]
14. Analysis of Drug-Induced Liver Injury from Bofutsushosan Administration Using Japanese Adverse Drug Event Report (JADER) Database.
Ishida T; Kawada K; Jobu K; Kawazoe T; Tamura N; Miyamura M
Biol Pharm Bull; 2022; 45(4):460-466. PubMed ID: 35370270
[TBL] [Abstract][Full Text] [Related]
15. Validation of the albumin-indocyanine green evaluation model in patients with resected hepatocellular carcinoma and comparison with the albumin-bilirubin score.
Russolillo N; Forchino F; Conci S; Mele C; Langella S; Ruzzenente A; Scoleri I; Giuliante F; Guglielmi A; Ferrero A
J Hepatobiliary Pancreat Sci; 2019 Jan; 26(1):51-57. PubMed ID: 30537424
[TBL] [Abstract][Full Text] [Related]
16. Albumin-Bilirubin Score Differentiates Liver Fibrosis Stage and Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Virus Infection: A Retrospective Cohort Study.
Fujita K; Nomura T; Morishita A; Oura K; Yoneyama H; Kobara H; Tsutsui K; Himoto T; Masaki T
Am J Trop Med Hyg; 2019 Jul; 101(1):220-225. PubMed ID: 31115300
[TBL] [Abstract][Full Text] [Related]
17. Combining albumin-bilirubin score with future liver remnant predicts post-hepatectomy liver failure in HBV-associated HCC patients.
Zou H; Wen Y; Yuan K; Miao XY; Xiong L; Liu KJ
Liver Int; 2018 Mar; 38(3):494-502. PubMed ID: 28685924
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of albumin-bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma.
Hiraoka A; Kumada T; Michitaka K; Toyoda H; Tada T; Ueki H; Kaneto M; Aibiki T; Okudaira T; Kawakami T; Kawamura T; Yamago H; Suga Y; Miyamoto Y; Tomida H; Azemoto N; Mori K; Miyata H; Ninomiya T; Kawasaki H
J Gastroenterol Hepatol; 2016 May; 31(5):1031-6. PubMed ID: 26647219
[TBL] [Abstract][Full Text] [Related]
19. Impact of albumin-bilirubin grade on survival in patients with hepatocellular carcinoma who received sorafenib: An analysis using time-dependent receiver operating characteristic.
Tada T; Kumada T; Toyoda H; Tsuji K; Hiraoka A; Michitaka K; Deguchi A; Ishikawa T; Imai M; Ochi H; Joko K; Shimada N; Tajiri K; Hirooka M; Koizumi Y; Hiasa Y; Tanaka J
J Gastroenterol Hepatol; 2019 Jun; 34(6):1066-1073. PubMed ID: 30549320
[TBL] [Abstract][Full Text] [Related]
20. The role of preoperative albumin-bilirubin grade for oncological risk stratification in liver transplant patients with hepatocellular carcinoma.
Kornberg A; Witt U; Schernhammer M; Kornberg J; Müller K; Friess H; Thrum K
J Surg Oncol; 2019 Dec; 120(7):1126-1136. PubMed ID: 31578753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
